compounded semaglutide impurities safety risks FDA is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified The Risks of Compounded Semaglutide

Key Insight : Spend on drug treatment within obesity episodes is over 6 times what it was 3 years ago

We caught up with experts from the Rooted Research Collective, who emphasized the urgent need for stricter regulations to combat this growing trend of misinformation

That's always a possibility

Even if you could get a prescription and pay at least $900 out of pocket for a four-week supply of Ozempic or $1,300 for Wegovy, you might show up at the pharmacy and find theyre all out

A physician-supervised medical weight loss program includes comprehensive health evaluations, personalized treatment plans, ongoing monitoring, medication management, and lifestyle coaching